logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10442857 B1

PDFFull Text
Expired
Date of Patent:
Oct. 15, 2019

Filed:

Sep. 01, 2016

Anti-il-17 antibodies

Applicant:

Closed Joint Stock Company “biocad”, Strelna, Petrodvortsoviy district, Saint Petersburg, RU;

Inventors:

Andrey Borisovich Ulitin, Puschino Moskovskaya obl., RU;

Stanislav Rudolfovich Evdokimov, Puschino Moskovskaya obl., RU;

Valeriy Vladimirovich Soloviev, Puschino Moskovskaya obl., RU;

Yulia Sergeevna Chernyh, Solikamsk Permsky kray, RU;

Olga Vladimirovna Goncharova, Lyubuchany Chekhovskiy r-n Moskovskaya.obl, RU;

Dmitriy Valerievich Korzhavin, St.Petersburg, RU;

Tatyana Veniaminovna Chernovskaya, Lyubuchany Chekhovskiy r-n Moskovskaya.obl, RU;

Roman Alexeevich Ivanov, Moscow, RU;

Dmitriy Valentinovich Morozov, Moscow, RU;

Assignee:

CLOSED JOINT STOCK COMPANY “BIOCAD”, Saint Petersburg, RU;

Attorney:

Anglehart et al.

Primary Examiner:

Dong Jiang

Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 2039/505 (2013.01); C07K 2317/22 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/52 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/90 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); Y02A 50/386 (2018.01); Y02A 50/41 (2018.01); Y02A 50/412 (2018.01);
Abstract

The present invention relates to the field of medicine, and specifically to the field of monoclonal antibodies against human IL-17. More specifically, the invention relates to monoclonal antibodies/antagonists of IL-17A, which bind with high affinity to an IL-17 epitope, wherein the antibodies contain amino acid substitutions in hypervariable regions of heavy and light chains. The antibodies according to this invention can be chimeric, humanized or human antibodies or antigen-binding fragments thereof, and can be used as a medicinal agent for treating autoimmune and inflammatory disorders and disorders of cell proliferation and development. The invention also relates to methods for producing said antibodies.

Find Patent Forward Citations

Ulitin, Andrey. (2019). Anti-il-17 antibodies (U.S. Patent No. 10442857). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10442857

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…